Sun Pharmaceutical Industries Ltd.
|
QUARTERLY RESULTS
|
|
You can view the
Quaterly Results
for the last 5 years.
Market Cap. (Rs.)
|
388824.23 Cr.
|
P/BV
|
6.94
|
Book Value (Rs.)
|
233.38
|
52 Week High/Low (Rs.)
|
1634/922
|
FV/ML
|
1/1
|
P/E(X)
|
45.89
|
Bookclosure
|
09/02/2024
|
EPS (Rs.)
|
35.32
|
Div Yield (%)
|
0.71
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 12156.86 | 12192.41 | 11785.15 | 10725.57 | 11100.14 |
Other Operating Income | 223.84 | 0.00 | 155.69 | 205.10 | 140.83 |
Total Income From Operations | 12380.70 | 12192.41 | 11940.84 | 10930.67 | 11240.97 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 1709.66 | 1665.45 | 1852.49 | 1899.94 | 1859.69 |
Purchase of Traded Goods | 796.49 | 1006.82 | 679.96 | 892.33 | 887.29 |
Increase/Decrease in Stocks | 230.79 | 114.82 | 225.72 | -542.05 | 56.69 |
Employees Cost | 2363.32 | 2364.36 | 2402.04 | 2179.55 | 2037.07 |
Depreciation | 622.14 | 632.82 | 651.32 | 671.53 | 659.95 |
Other Expenses | 3803.61 | 3861.58 | 3448.86 | 3698.77 | 3396.51 |
Total Expenses | 9526.01 | 9645.85 | 9260.39 | 8800.07 | 8897.20 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 2854.69 | 2546.56 | 2680.45 | 2130.60 | 2343.77 |
Other Income | 250.20 | 293.61 | 204.44 | 373.28 | 173.88 |
P/L Before Interest, Excpt. Items & Tax | 3104.89 | 2840.17 | 2884.89 | 2503.88 | 2517.65 |
Interest | 34.73 | 49.29 | 80.88 | 92.74 | 46.18 |
P/L Before Exceptional Items & Tax | 3070.16 | 2790.88 | 2804.01 | 2411.14 | 2471.47 |
Exceptional Items | -69.81 | 0.00 | -322.87 | -171.45 | 0.00 |
P/L Before Tax | 3000.35 | 2790.88 | 2481.14 | 2239.69 | 2471.47 |
Tax | 432.32 | 390.10 | 468.10 | 222.91 | 283.43 |
P/L After Tax from Ordinary Activities | 2568.03 | 2400.78 | 2013.04 | 2016.78 | 2188.04 |
Net Profit/Loss For the Period | 2568.03 | 2400.78 | 2013.04 | 2016.78 | 2188.04 |
Minority Interest | -36.79 | -9.59 | 16.89 | 1.57 | -14.74 |
Share Of P/L Of Associates | -7.49 | -15.68 | -7.39 | -33.88 | -7.29 |
Net P/L After Minority Interest & Share Of Associates | 2523.75 | 2375.51 | 2022.54 | 1984.47 | 2166.01 |
| | | | | |
Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 10.50 | 9.90 | 8.40 | 8.30 | 9.00 |
Diluted EPS (Rs.) | 10.50 | 9.90 | 8.40 | 8.30 | 9.00 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 10.50 | 9.90 | 8.40 | 8.30 | 9.00 |
Diluted EPS (Rs.) | 10.50 | 9.90 | 8.40 | 8.30 | 9.00 |
| | | | | |
PBITOE Margin (%) | 23.05 | 20.88 | 22.44 | 19.49 | 20.85 |
PBTE Margin (%) | 24.79 | 22.89 | 23.48 | 22.05 | 21.98 |
PBT Margin (%) | 24.23 | 22.89 | 20.77 | 20.48 | 21.98 |
PAT Margin (%) | 20.74 | 19.69 | 16.85 | 18.45 | 19.46 |
PAT After MI And SOA Margin (%) | 20.38 | 19.48 | 16.93 | 18.15 | 19.26 |